Serum Lysozyme Levels and Clinical Features of Sarcoidosis

@article{Tomita1999SerumLL,
  title={Serum Lysozyme Levels and Clinical Features of Sarcoidosis},
  author={Hiroshi Tomita and S. Sato and R. Matsuda and Yoshiki Sugiura and Haruhiko Kawaguchi and Takashi Niimi and Shinichi Yoshida and M. Morishita},
  journal={Lung},
  year={1999},
  volume={177},
  pages={161-167}
}
Abstract. Serum lysozyme is used as a marker of sarcoidosis disease activity. In this study we examined the association between lysozyme levels and the clinical features of sarcoidosis and thus the clinical usability of this parameter in a large population. One hundred ten sarcoidosis patients from central Japan were examined for clinical features and serum lysozyme level at the first visit to our hospital and on a regular basis thereafter. The sensitivity of lysozyme for predicting sarcoidosis… 
View on Springer
ncbi.nlm.nih.gov
52 Citations
Highly Influential Citations
1
Background Citations
15
Results Citations
1

52 Citations

Citation Type

Citation Type

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
TLDR
KL-6 is a reliable biomarker of fibrotic lung involvement in sarcoidosis patients and among biomarkers, KL-6 showed the best sensitivity and serum chitotriosidase the best specificity, even in patients on chronic steroid therapy, and seemed to correlate with extrapulmonary localizations.
Comparative evaluation of serum markers in pulmonary sarcoidosis.
TLDR
Serum levels of sIL-2R, lysozyme, and KL-6 were significantly correlated with the numbers of total cells, lymphocytes, and CD4(+) T lymphocytes in BALF, and univariate and multivariate analyses revealed that only KL- 6 was a predictor of increased parenchymal infiltration.
The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases
TLDR
Elevated serum angiotensin converting enzyme levels are significant for patients with presumed sarcoidosis compared to ocular involvement of other autoimmune diseases such as behcet’s disease and ankylosing spondylitis, and ocular involved of infectious diseases suchAs presumed latent tuberculosis and presumed latent syphilis.
Serum Vascular Endothelial Growth Factor as a Possible Prognostic Indicator in Sarcoidosis
TLDR
Serum VEGF values in patients with sarcoidosis is a predictive factor in determining extrathoracic organ involvements and as a parameter for deciding the necessity of treatment with corticosteroid and might be a useful marker as a prognostic indicator in sar coidosis.
Immunological markers of cell activation in sarcoidosis
TLDR
The results described in this thesis support the use of cell activation markers as sarcoidosis disease parameters, in addition to existing parameters including disease marker levels in serum, evolution of chest x-ray, and lung function data.
Laboratory Investigations and Immunological Testing in Sarcoidosis
TLDR
There is currently no definitive single laboratory investigation used to identify sarcoidosis, indicating the need for improved understanding of the immuno‐ pathogenesis and identification of disease-specific biomarkers.
Serological biomarkers of granuloma progression in sarcoidosis
TLDR
Common serological markers are overviewed, including angiotensin converting enzyme (ACE) and lysozyme, and new promising indices in sarcoidosis such as a T cell serological marker (soluble interleukin 2 receptor; sIL-2R) and thymus and activation-regulated chemokine (TARC/CCL17).
Identification and Assessment of Plasma Lysozyme as a Putative Biomarker of Atherosclerosis
TLDR
Raised plasma lysozyme levels may be a useful biomarker of atherosclerotic cardiovascular disease and response to therapy in patients presenting with chronic stable angina pectoris.
An update on the diagnosis and management of ocular sarcoidosis.
TLDR
D diagnosis and treatment options for ocular sarcoidosis have changed over time, however, challenges still exist in some difficult patients, and future studies should focus on finding more sensitive biomarkers and developing more effective immunomodulatory treatments with longer efficacy and less side effects.
Orbital and Adnexal Sarcoidosis
TLDR
Management involves observation in asymptomatic patients, while corticosteroid and steroid-sparing immunosuppressive agents are the mainstay of treatment.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis.
TLDR
Measurement of these enzymes may help in the management of some cases of sarcoidosis, but results require critical interpretation.
Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity.
TLDR
Serum lysozyme (LZM) determinations were done in 84 patients with clinically proven sarcoidosis and an increased LZM activity was demonstrated in Patients with pulmonary stage I and stage II disease, as well as in patients with extrapulmonary lesions.
Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis.
TLDR
Serum lysozyme levels appear to be a more useful marker of overall disease activity in sarcoidosis than measurements of other inflammatory markers, and BAL lymphocyte counts were the best predictive marker of radiographic response to corticosteroids.
Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis.
TLDR
There are several reasons to suggest that serum lysozyme, a low-molecular-weight lysosomal enzyme, has limited antibacterial properties, and is frequently present in the urine when there is high serum activity or renal tubular damage.
Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons.
TLDR
Serum angiotensin-converting enzyme (ACE) activity was studied in healthy controls, in 57 untreated sarcoidosis patients, and in 164 patients with other chest or lymph node diseases to indicate ACE production in certain diseases involving macrophages may be due to the bradykinin inhibiting effect of this enzyme.
Relationship between angiotensin-converting enzyme and lysozyme in sarcoidosis.
TLDR
Both enzymes are suitable for disease monitoring, but in most cases the more specific SACE must be preferred as a measure of disease activity, although SLZ seems to be a little more sensitive.
Serum lysozyme in pulmonary tuberculosis
TLDR
Evidence is presented to show that chronic tissue inflammation is the most likely source of the increased serum lysozyme activity in patients with active pulmonary tuberculosis.
Angiotensin converting enzyme. IV. Changes in serum activity and in lysozyme concentrations as indicators of the course of untreated sarcoidosis.
TLDR
It is concluded that ACE may be a secondary feature of sarcoidosis rather than a primary funtion of macrophage activity, and stable ACE activity during inactive sarcoids indicated the usefulness of measurements when trying to predict a relapse.
Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis.
TLDR
New normal ranges of serum ACE level were determined for each genotype, and found to be 22% more sensitive overall than the conventional normal range and 39% more so for II type, suggesting an advantage for diagnosis and assessment of the disease activity of sarcoidosis.
A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE.
TLDR
Lysozymuria has been reported in some children with nephrotic syndrome and in some adults with renal disease, but no definitive evidence of the source of urinary lysozyme is available.
...
1
2
3
...